ZyVersa Therapeutics, Inc. ZVSA
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.22% | -93.35% | 329.62% | -39.67% | -20.76% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.87% | 25.26% | 11.48% | -27.44% | -42.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -64.83% | -79.72% | 154.99% | -14.39% | -27.23% |
|
|
|||||
| Total Current Assets | -64.83% | -79.72% | 154.99% | -14.39% | -27.23% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -88.41% | 148.80% | 130.76% |
| Total Assets | -96.46% | -98.31% | -94.64% | 0.88% | -3.07% |
|
|
|||||
| Total Accounts Payable | 6.57% | 8.42% | 5.61% | 17.53% | 18.17% |
| Total Accrued Expenses | 34.24% | 34.98% | 28.47% | 74.03% | 65.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2,921.92% | 783.56% | 858.90% | 0.00% | 0.00% |
| Total Other Current Liabilities | 2,921.92% | 783.56% | 858.90% | 0.00% | 0.00% |
| Total Current Liabilities | 23.85% | 13.39% | 10.60% | 26.96% | 25.26% |
|
|
|||||
| Total Current Liabilities | 23.85% | 13.39% | 10.60% | 26.96% | 25.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -0.34% | 0.80% |
| Total Liabilities | 15.65% | 5.39% | 2.98% | 24.81% | 23.28% |
|
|
|||||
| Common Stock & APIC | 1.82% | 3.34% | 5.87% | 4.91% | 4.90% |
| Retained Earnings | -21.32% | -22.15% | -23.11% | -7.62% | -8.34% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -273.72% | -245.45% | -266.86% | -29.24% | -27.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -273.72% | -245.45% | -266.86% | -29.24% | -27.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -273.72% | -245.45% | -266.86% | -29.24% | -27.56% |
|
|
|||||